Stem Cell Therapy for Lupus in Thailand
An immunomodulatory approach for systemic lupus erythematosus
Understanding Lupus (Systemic Lupus Erythematosus)
Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which the immune system produces antibodies that attack healthy tissues throughout the body, potentially affecting the skin, joints, kidneys, brain, heart, and lungs. The disease is characterised by periods of flares and remission, with chronic inflammation driving progressive organ damage over time. Standard treatment relies heavily on corticosteroids, antimalarials, and immunosuppressive agents, which carry significant long-term side effects including infection susceptibility, bone loss, and organ toxicity. Mesenchymal stem cells have shown promise in clinical research for their ability to modulate the dysregulated immune response in lupus, particularly through suppression of autoreactive B and T cells and promotion of regulatory immune cell populations. Treatment is delivered at Boston Health Longevity in Chiang Mai with rigorous patient selection and comprehensive monitoring protocols.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Lupus (Systemic Lupus Erythematosus)?
Genetic susceptibility involving multiple gene variants related to immune regulation, complement pathways, and cell signalling. Having a close family member with lupus or another autoimmune disease significantly increases risk.
Hormonal influences play a substantial role, with lupus affecting women approximately nine times more frequently than men. Oestrogen is believed to enhance immune reactivity, which may explain why onset commonly occurs during reproductive years.
Environmental triggers including ultraviolet light exposure, certain infections (particularly Epstein-Barr virus), silica dust exposure, and certain medications can activate or worsen the disease in genetically susceptible individuals.
Immune system dysfunction leads to loss of self-tolerance, where the body produces autoantibodies (including anti-dsDNA and anti-Smith antibodies) that form immune complexes depositing in tissues and driving inflammation.
Defective clearance of apoptotic cells (cellular debris) means nuclear material is exposed to the immune system, triggering autoantibody production and perpetuating the autoimmune cycle.
Common Signs and Symptoms
Profound fatigue that is disproportionate to activity levels, often described by patients as the most debilitating aspect of the disease. This fatigue does not resolve with rest and can be severely disabling.
Joint pain, swelling, and stiffness affecting multiple joints (polyarthralgia), commonly the hands, wrists, and knees. Unlike rheumatoid arthritis, lupus joint involvement is often migratory and non-erosive.
The characteristic butterfly-shaped (malar) rash across the cheeks and nose, present in approximately 50% of patients. Photosensitive rashes may also develop on sun-exposed areas of the body.
Kidney involvement (lupus nephritis) occurring in up to 50% of patients, potentially causing proteinuria, oedema, hypertension, and if untreated, progressive renal failure.
Neuropsychiatric manifestations including cognitive dysfunction ("lupus fog"), headaches, mood disturbances, and in severe cases, seizures or psychosis.
Recurrent oral or nasal ulcers, hair loss (alopecia), Raynaud phenomenon (fingers turning white or blue in cold), and pleuritic chest pain from inflammation of the lung or heart lining.
Living With Lupus (Systemic Lupus Erythematosus)
Living with lupus often means navigating a disease that is invisible to others yet profoundly disabling. You may look well on the outside while battling crushing fatigue, joint pain, and the constant anxiety of not knowing when the next flare will strike. Sun exposure, stress, even a simple cold can trigger a cascade of symptoms that confines you to bed for days or weeks. Many patients describe the frustration of having to cancel plans, reduce work hours, or step back from family responsibilities without warning. The medications that keep your disease in check come with their own burden: weight gain from steroids, infection vulnerability from immunosuppressants, and the emotional toll of long-term pharmaceutical dependence. If you are reading this, you likely understand the exhausting reality of managing a disease that demands constant vigilance while offering little predictability.
Conventional Treatment Options
Standard lupus management relies on a combination of hydroxychloroquine (antimalarial) as baseline therapy, with corticosteroids used to control flares and immunosuppressive agents (mycophenolate, azathioprine, cyclophosphamide) for organ-threatening disease. Biologic agents such as belimumab have been approved for active lupus. While these treatments can be effective at controlling disease activity, they carry substantial long-term consequences: corticosteroids cause osteoporosis, diabetes, cataracts, and adrenal suppression; immunosuppressants increase infection risk and may cause liver or bone marrow toxicity; and cyclophosphamide carries fertility risks. Many patients spend years cycling through medications, balancing disease control against side effect burden, leading them to explore complementary approaches that may help modulate the immune system with a more favourable risk profile.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Patients with moderate to severe systemic lupus erythematosus who have not achieved adequate disease control with conventional therapies including hydroxychloroquine, corticosteroids, and immunosuppressants may be candidates. Those experiencing recurrent flares despite standard treatment, or who are seeking to reduce their immunosuppressive medication burden due to side effects, should be assessed. A thorough rheumatological evaluation including autoantibody panels, organ function assessment, and disease activity scoring is required.
Contraindications
Clinical outcomes for lupus (systemic lupus erythematosus)
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
64%
Symptom Reduction
Average improvement in disease activity scores across autoimmune conditions treated
52%
Medication Reduction
Patients able to reduce immunosuppressive medication with physician guidance
3-6 mo
Response Timeline
Typical period for immune modulation effects to become clinically measurable
78%
Flare Reduction
Patients reporting fewer or less severe disease flares in 12-month follow-up
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Lupus (Systemic Lupus Erythematosus) Treatment
Umbilical cord-derived MSC therapy for lupus is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced immunomodulatory therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Complex systemic autoimmune condition treatments range from $25,000 to $50,000 USD, with a clear breakdown provided during your no-obligation consultation.
Chiang Mai offers a warm, supportive recovery environment. The clinic is located away from the intensity of Bangkok, providing a relaxed setting where patients can focus on recovery and healing.
Structured follow-up at 1, 3, 6, and 12 months via secure video consultation with laboratory monitoring ensures your autoantibody levels, organ function, and disease activity are tracked objectively long after you return home.
Alternatives to immunosuppressants for lupus
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $25,000 - $50,000 | N/A (no surgical equivalent) |
| Recovery Time | Varies by protocol | Ongoing (continuous medication management) |
| Invasiveness | Minimally invasive intravenous infusion | Long-term immunosuppressants / corticosteroids |
| Hospital Stay | Varies by protocol | Outpatient (ongoing specialist visits) |
| Risk Level | Low (cell-based, minimal side effects) | Moderate-High (infection, organ toxicity, bone loss) |
| Return to Normal Activity | Varies by protocol | Continuous treatment with variable side effects |
Treatment at Boston Health Longevity
$25,000 - $50,000
USD equivalent, personalised to your case
vs Home Country
N/A (no surgical equivalent)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Comprehensive remote consultation with review of rheumatology records and laboratory results
Arrive in Chiang Mai, accommodation and logistics support provided
Day 1: Detailed clinical assessment, autoantibody panels, organ function tests, and disease activity scoring
Day 2: Stem cell preparation and intravenous administration with monitoring
Day 3-5: Close monitoring, follow-up blood work, and discharge with comprehensive care plan
Structured remote follow-up at 1, 3, 6, and 12 months with laboratory monitoring
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cell therapy cure lupus?
How does this differ from a stem cell transplant for lupus?
Will my lupus medications need to change?
What outcomes have been observed in lupus patients?
Ready to explore lupus (systemic lupus erythematosus) treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
Related treatments & resources
Conditions We Treat
- Crohn's Disease
- Ulcerative Colitis
- Tendon Injuries
- Type 2 Diabetes Support
- Chronic Wound Healing
- Alzheimer's & Dementia
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for lupus (systemic lupus erythematosus) treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours